| 引用本文: | 方灵芝,曹格溪,关丽叶,张玥,董占军.某院门诊甲氨蝶呤片超说明书使用的循证医学分析与管理[J].中国现代应用药学,2020,37(16):1993-1997. |
| FANG Lingzhi,CAO Gexi,GUAN Liye,ZHANG Yue,DONG Zhanjun.Evidence-based Medical Analysis and Management of Off-label Use of Methotrexate in A Hospital's Outpatients[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(16):1993-1997. |
|
| 摘要: |
| 目的 通过循证医学的方法评价和规范甲氨蝶呤片的合理用药。方法 回顾性调取河北省人民医院2018年1月-2019年6月甲氨蝶呤片门诊处方1 011张，对超说明书用药的处方进行分类统计，并通过Micromedex的Thomson分级系统进行评价，根据评价结果给出超说明书用药的推荐意见及干预措施。结果 甲氨蝶呤片超说明书使用的主要类型为超适应证用药，占比90.7%，其次为超单次剂量，占比37.4%，发生率最高的科室为风湿免疫科；发生率排名前3的临床诊断为类风湿性关节炎，其次为原发性干燥综合征、皮肌炎。据超说明书用药的循证分析结果及笔者所在医院超说明书管理制度，超适应证用药的临床诊断共4种，同意使用的有3种，限制使用的1种；超适应证同时超单次剂量用药的临床诊断有6种，同意使用的6种；超单次剂量用药的临床诊断有1种，评价结果为同意使用。结论 甲氨蝶呤片超说明书用药现象普遍存在，须严格执行超说明书用药管理制度，促进临床合理用药。 |
| 关键词: 甲氨蝶呤 循证医学 超说明书 |
| DOI：10.13748/j.cnki.issn1007-7693.2020.16.013 |
| 分类号:R969.4 |
| 基金项目:河北省2019年度医学科学研究课题计划（20190401） |
|
| Evidence-based Medical Analysis and Management of Off-label Use of Methotrexate in A Hospital's Outpatients |
|
FANG Lingzhi, CAO Gexi, GUAN Liye, ZHANG Yue, DONG Zhanjun
|
|
Department of Pharmacy, Hebei People's Hospital, Shijiazhuang 050051, China
|
| Abstract: |
| OBJECTIVE To evaluate the clinical use and standardize rational drug use of methotrexate through evidenced-based medicine. METHODS A retrospective survey of 1 011 prescription for methotrexate tablets from outpatient of Hebei People's Hospital from January 2018 to June 2019 was conducted. The prescription in which methotrexate was used off-label were categorized and evaluated by Thomson grading system of Micromedex. According to the results of evaluation, the recommendations and intervention measures of off-label use were given out. RESULTS The main type of off-label use of methotrexate tablets was super indication, accounting for 90.7%, followed by super single dose, accounting for 37.4%, the highest incidence department was rheumatology. The top three clinical diagnoses were rheumatoid arthritis, Sjögren's, dermatomyositis. According to the hospital's off-label management system, analyzing evidence-based medical evidence, there were 4 types of extra-indication which 3 types were agreed to use, and one type was limited use. Six types of extra-indication and over single use at the same time were agreed to use. A type of over single was agreed to use. CONCLUSION It is a widespread phenomenon of the off-label use of methotrexate tablets. It must be strictly implement off label management system to promote safe medication. |
| Key words: methotrexate evidence-based medicine off-label |
